CDH3 and cancer: Of note, immunoreactivity analysis has provided preliminary evidence of mis-localization of CDH3 in PCa cells compared to non-tumoral counterparts, Interestingly, this alteration is also observed in other cancers and is associated to poor prognosis [59].